Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Milademetan tosylate hydrate

Cat. No.: IBDI-432993

Milademetan (DS-3032) tosylate hydrate is a specific and orally active MDM2 inhibitor for the research of acute myeloid leukemia (AML) or solid tumors. Milademetan (DS-3032) tosylate hydrate induces G1 cell cycle arrest, senescence and apoptosis.

Size (Solid):

Product Details

Target MDM-2/p53 | E1/E2/E3 Enzyme | Apoptosis
Molecular Weight 808.74
Appearance Solid
Synonyms DS-3032b, DS-3032 tosylate hydrate
SMILES CC1=CC=C(S(=O)(O)=O)C=C1.O=C2NC3=CC(Cl)=CC=C3[[email protected]]24C5(N[[email protected]]([[email protected]@H]4C6=CC=NC(Cl)=C6F)C(N[[email protected]@H]7CC[[email protected]](OC7)C(N)=O)=O)CCC(C)(CC5)C.[H]O[H]
Purity 98.21%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.